INSPIRE & DRIVE 1 – How to get to the top
Created by: Constantino Fondevila, Barcelona, Spain; Vassilios Papalois, London, United Kingdom
Outline | Navigate transplant professionals as to how they can direct their efforts to advance their professional development and reach positions of responsibility leadership and esteem to shape the future of the world of transplantation.
INSPIRE & DRIVE 2 – Evidence Based Practice is killing the art of medicine
Created by: Franz Immer, Zurich, Switzerland; Vassilios Papalois, London, United Kingdom
Outline | The session aims to appraise to what extent evidence based practice is a driving force or a limitation for innovation and progress in the field of medicine and especially transplantation.
INSPIRE & DRIVE 3 – Relight my fire – “GET BACK OUT THERE AND TRY IT AGAIN.”
Created by: Ina Jochmans, Leuven, Belgium; Nicos Kessaris, London, United Kingdom
Outline | What would you do if you had a history of depression, suicidal ideation or substance abuse? What would you do when ‘the light just goes out’ and you find yourself burned out? Learn first hand from a team of experts how mental health challenges can be recognised and overcome. Help us open the discussion on the importance of self-care and how we can break the stigma associated with mental health challenges such as burnout and depression in healthcare workers.
INSPIRE & DRIVE 4 – WHAT KEEPS ME GOING, WHAT MAKES ME HAPPY: Redefining transplantation success – starting with new clinically relevant endpoints?
Created by: Erik Berglund, Stockholm, Sweden; Andreas Zuckermann, Vienna, Austria
Outline | For a long time transplantation has relied on a few primary short-term focused end-points to determine transplantation success. The low rates of early acute rejection and the, from a clinical trial perspective, already relatively long timespan between transplantation and graft failure has resulted in a decreasing transplantation treatment pipeline. As many patients are still suffering from graft loss long-term, the focus among clinicians has gradually shifted to improve long-term outcomes. Several initiatives are addressing what new principles could potentially allow for the development of novel therapies that benefit our patients beyond the traditionally used end-points.
The main objective with the session is to inspire interactive discussion around what novel end-points and validated surrogate markers could be used to redefine long-term success, ultimately approved by regulators. Such redefinition requires the drive, involvement and collaboration by and between individuals, patients, institutions, transplant societies, health authorities and regulatory bodies. The session is focused mainly on kidney transplantation and the conclusions are likely applicable to other organs.
|PLEASE CLICK ON THE IMAGE TO GO TO THE SECOND ANNOUNCEMENT|